These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18461185)

  • 21. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
    Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P
    J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the effect of market forces on the impact of introducing human immunodeficiency virus pre-exposure prophylaxis among female sex workers.
    Quaife M; Terris-Prestholt F; Mukandavire Z; Vickerman P
    Health Econ; 2021 Mar; 30(3):659-679. PubMed ID: 33377250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South India.
    Reza-Paul S; Lazarus L; Doshi M; Hafeez Ur Rahman S; Ramaiah M; Maiya R; Ms V; Venukumar KT; Sundararaman S; Becker M; Moses S; Lorway R
    PLoS One; 2016; 11(11):e0166889. PubMed ID: 27880833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
    Corneli A; Namey E; Ahmed K; Agot K; Skhosana J; Odhiambo J; Guest G
    AIDS Patient Care STDS; 2015 Sep; 29(9):503-9. PubMed ID: 26196411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
    J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.
    Alsallaq RA; Buttolph J; Cleland CM; Hallett T; Inwani I; Agot K; Kurth AE
    PLoS One; 2017; 12(4):e0175447. PubMed ID: 28403211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    Stelzle D; Godfrey-Faussett P; Jia C; Amiesimaka O; Mahy M; Castor D; Hodges-Mameletzis I; Chitembo L; Baggaley R; Dalal S
    PLoS Med; 2021 Jan; 18(1):e1003482. PubMed ID: 33428611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study.
    Goodreau SM; Hamilton DT; Jenness SM; Sullivan PS; Valencia RK; Wang LY; Dunville RL; Barrios LC; Rosenberg ES
    J Adolesc Health; 2018 Mar; 62(3):311-319. PubMed ID: 29248392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.
    Nichols BE; Boucher CA; van Dijk JH; Thuma PE; Nouwen JL; Baltussen R; van de Wijgert J; Sloot PM; van de Vijver DA
    PLoS One; 2013; 8(3):e59549. PubMed ID: 23527217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study.
    Gantenberg JR; King M; Montgomery MC; Galárraga O; Prosperi M; Chan PA; Marshall BDL
    PLoS One; 2018; 13(7):e0199915. PubMed ID: 29985949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global epidemiology of HIV among female sex workers: influence of structural determinants.
    Shannon K; Strathdee SA; Goldenberg SM; Duff P; Mwangi P; Rusakova M; Reza-Paul S; Lau J; Deering K; Pickles MR; Boily MC
    Lancet; 2015 Jan; 385(9962):55-71. PubMed ID: 25059947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?" the condom quandary among PrEP users and health care providers in Kenya.
    Irungu EM; Ngure K; Mugwanya KK; Awuor M; Dollah A; Ongolly F; Mugo N; Bukusi E; Wamoni E; Odoyo J; Morton JF; Barnabee G; Mukui I; Baeten JM; O'Malley G;
    AIDS Care; 2021 Jan; 33(1):92-100. PubMed ID: 32207327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.
    Nagelkerke NJ; Moses S; de Vlas SJ; Bailey RC
    BMC Infect Dis; 2007 Mar; 7():16. PubMed ID: 17355625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya.
    Bazzi AR; Yotebieng K; Otticha S; Rota G; Agot K; Ohaga S; Syvertsen JL
    J Int AIDS Soc; 2019 Apr; 22(4):e25266. PubMed ID: 30983147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysis.
    Vickerman P; Foss AM; Pickles M; Deering K; Verma S; Eric Demers ; Lowndes CM; Moses S; Alary M; Boily MC
    AIDS; 2010 Oct; 24(16):2563-72. PubMed ID: 20852405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.